Head-to-Head

Bicara Therapeutics Inc. Common Stock vs. Johnson & Johnson

BCAX

Bicara Therapeutics Inc. Common Stock

$9.76 -44.16%

VS JNJ

Johnson & Johnson

$271.06 +0.87%

Johnson & Johnson (JNJ) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

BCAXJNJ
Market Cap $1.16 billion $646.92 billion

JNJ leads on 1 of 1 size & scale factors.

Dividend

BCAXJNJ
Dividend Yield — 1.98%

BCAX and JNJ split the dividend factors evenly.

Risk & Sentiment

BCAXJNJ
Short Interest 1.00% 0.67%

JNJ leads on 1 of 1 risk & sentiment factors.

Dig deeper: BCAX overview, BCAX financials, JNJ overview, JNJ financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.